oral glp-1 inhibitor Orforglipron, an Small-Molecule Receptor Agonist, in Early Type 2 Diabetes Oral GLP-1 Orforglipron Is Approved
Description
Considering IVY RX for weight loss
More than appetite support
The timing wasnt ideal, but the rationale is clear
Pagina que reune las diferentes entradas de 1aria sobre Ar-GLP1
SGLT2 inhibitors, used in the treatment of type 2 DM, have an average half-life of 11-13 hours, so most articles suggested withholding the drug three days before any elective surgery but some articles suggested a longer withholding period based on other precipitating factors contributing to euglycemic DKA
